Immunology Quality Assessment (HIV) - Clinical Trial

What is the Purpose of this Study?


We are doing this study to collect blood donations from those who have HIV to make sure laboratories across the United States and other countries are testing their blood to know and help support the course of HIV and other infectious diseases of the immune system as well as look at possible vaccines.

What is the Condition Being Studied?

Collecting blood from those with HIV

Who Can Participate in the Study?

Key Eligibility

Adults who:
- Have HIV
- Have a hemoglobin of 12.5 or higher
- Willing to donate a pint of blood

If you need assistance in understanding if you can participate, please contact the study team.

Age Group

What is Involved?


If you choose to join this study, you will:
- Have a short pre-screening visit to draw blood for testing purposes
- Have your hemoglobin checked to make sure you are not anemic (low iron)
- Have your CD4 count measured and to see how much HIV is in your blood
- Have a large blood draw of about a pint or blood draw of up to about half a cup
-- You may not have more than 550mls (about a cup and a half) of blood drawn within an 8-week period including from this study, other studies and/or routine medical care
- Be involved in this study for several years to come back in to have blood drawn

Study Details

Full Title
Blood Draw for the Immunology Quality Assessment Programs at Duke University Medical Center (QAP)
Principal Investigator
Thomas Denny
Protocol Number
IRB: PRO00008576
Enrollment Status
Open for Enrollment